Day-to-day discrepancy in Bravo pH monitoring is related to the degree of deterioration of the lower esophageal sphincter and severity of reflux disease

BACKGROUND: The Bravo capsule allows monitoring of esophageal acid exposure over a two-day period. Experience has shown that 24–32% of patients will have abnormal esophageal acid exposure detected on only one of the 2 days monitored. This variation has been explained by the effect of endoscopy and s...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Ayazi, Shahin, Hagen, Jeffrey A., Zehetner, Joerg, Banki, Farzaneh, Augustin, Florian, Ayazi, Ali, DeMeester, Steven R., Oh, Daniel S., Sohn, Helen J., Lipham, John C., DeMeester, Tom R.
פורמט: Artigo
שפה:Inglês
יצא לאור: Springer-Verlag 2011
נושאים:
Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC3116124/
https://ncbi.nlm.nih.gov/pubmed/21359906
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00464-010-1529-5
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים